Loading
Latest filing published 22 Apr 2019 for Clementia Pharmaceuticals Inc., €1.2M.
No signal scores available.
Donna Roy Grogan is a declared insider of Clementia Pharmaceuticals Inc., with filings sourced from SEDI. We count 2 filings; the first trade dates from 14 August 2017 and the latest from 17 April 2019.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 22 April 2019 came the latest disclosure, a transaction for €1.2M in Clementia Pharmaceuticals Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations